UnitedHealth Group Q3 2026 Earnings Call Transcript - UnitedHealth Group (NYSE:UNH)
UnitedHealth Group (NYSE:UNH) reported Q3 2026 revenue of $113 billion and adjusted EPS of $4.69, with strong performance across UnitedHealthcare and Optum. The company is investing in AI and technology to improve care quality and reduce costs, aiming for 2026 adjusted EPS of at least $20.50 and long-term growth of 13% to 16%. UnitedHealthcare is seeing positive momentum in Medicare and Medicaid, focusing on value-based care offerings.
How this was made
The 30-second read
Why it matters
The earnings beat and raised EPS guidance provide fresh material for traders to adjust positions.
Market read
First‑report earnings for a mega‑cap health insurer with strong results and guidance, high trading relevance.
What to watch
Potential cost pressures from specialty pharmacy and acute care intensity could temper margins.
Background
UnitedHealth Group released its Q3 2026 earnings call transcript, detailing financial results and strategic initiatives.
Ticker impact
Q3 2026 earnings released with $113B revenue and $4.69 adjusted EPS, plus guidance of $20.50 adjusted EPS for 2026.
likely upward as market prices in strong earnings and raised guidance
Revenue and EPS beat, plus higher full‑year EPS guidance, are fresh primary data for a large‑cap health insurer.
Market effects
Strong health‑insurer earnings may lift broader healthcare and insurance sector.
U.S. market may see modest gains in health‑care indices.
Limited; primarily U.S. health‑care investors.
Counterpoint
If guidance is overly optimistic, future earnings could miss, prompting a pull‑back.
Key entities
- companyUnitedHealth Group
Large U.S. health insurer and provider.
- executiveSteve Hensley
Chairman and CEO who presented the earnings.



